PT - JOURNAL ARTICLE ED - , TI - Spironolactone of no benefit in people with AF and HFpEF AID - 10.1136/dtb.2021.000058 DP - 2021 Dec 01 TA - Drug and Therapeutics Bulletin PG - 181--181 VI - 59 IP - 12 4099 - http://dtb.bmj.com/content/59/12/181.short 4100 - http://dtb.bmj.com/content/59/12/181.full SO - Drug Ther Bull2021 Dec 01; 59 AB - Overview of: Shantsila E, Shahid F, Sun Y, et al. Spironolactone to improve exercise tolerance in people with permanent atrial fibrillation and preserved ejection fraction: the IMPRESS-AF RCT. Efficacy Mech Eval 2020; 7(4).